Alcon Sues Apotex Over Generic Allergy Spray

Law360, New York (August 26, 2011, 3:39 PM EDT) -- Alcon Pharmaceuticals Ltd. filed a patent infringement suit against Apotex Inc. in Texas on Thursday in an effort to keep the Canadian drug company from developing its own version of seasonal allergy relief nasal spray Patanase.

Alcon, a subsidiary of Novartis AG, lodged the suit in response to Apotex's filing of an abbreviated new drug application with the U.S. Food and Drug Administration to sell a generic olopatadine hydrochloride product before the plaintiff's patent for the drug expires.

Alcon claims that Apotex's ANDA infringes U.S. Patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.